• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其风湿病联盟共识报告:中轴型脊柱关节炎管理建议

Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis.

作者信息

Bodur Hatice, Yurdakul Fatma Gül, Ataman Şebnem, Garip Yeşim, Nas Kemal, Fikriye Figen Ayhan Fikriye Figen Ayhan, Akgül Özgür, Akinci Ayşen, Altay Zuhal, Birtane Murat, Soy Buğdayci Derya, Çapkin Erhan, Çevik Remzi, Duruöz Tuncay, Gürer Gülcan, Kaçar Cahit, Kamanli Ayhan, Kaptanoğlu Ece, Kaya Taciser, Kocabaş Hilal, Kuru Ömer, Melikoğlu Meltem Alkan, Özdemirel Erhan, Özel Sumru, Rezvani Aylin, Sezer İlhan, Sunar İsmihan, Yilmaz Gürkan

机构信息

Department of Physical Medicine and Rehabilitation, Yıldırım Beyazıt University School of Medicine, Ankara, Turkey.

Department of Physical Medicine and Rehabilitation, SBÜ Ankara Numune Training and Research Hospital, Ankara, Turkey.

出版信息

Arch Rheumatol. 2018 Feb 14;33(1):1-16. doi: 10.5606/ArchRheumatol.2018.6833. eCollection 2018 Mar.

DOI:10.5606/ArchRheumatol.2018.6833
PMID:29900976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5864166/
Abstract

OBJECTIVES

This study aims to update 2011 Turkish League Against Rheumatism SpondyloArthritis Recommendations, and to compose a national expert opinion on management of axial spondyloArthritis under guidance of current guidelines, and implantation and dissemination of these international guidelines into our clinical practice.

PATIENTS AND METHODS

A scientific committee of 28 experts consisting of 14 rheumatologists and 14 physical medicine and rehabilitation specialists (one of them also has an immunology PhD) was formed. The recommendations, systematic reviews, and meta-analyses including pharmacologic and non-pharmacologic treatment were scrutinized paying special attention with convenient key words. The draft of Turkish League Against Rheumatism opinion whose roof consisted of international treatment recommendations, particularly the Assessment of SpondyloArthritis International Society/European League Against Rheumatism recommendations was composed. Assessment of level of agreement with opinions by task force members was established through the Delphi technique. Voting using a numerical rating scale assessed the strength of each recommendation.

RESULTS

Panel compromised on five basic principles and 13 recommendations including pharmacological and nonpharmacological methods. All of the recommendations had adequate strength.

CONCLUSION

Turkish League Against Rheumatism expert opinion for the management of axial spondyloArthritis was developed based on scientific evidence. These recommendations will be updated regularly in accordance with current developments.

摘要

目的

本研究旨在更新2011年土耳其风湿病联盟脊柱关节炎指南,在当前指南的指导下就轴性脊柱关节炎的管理形成国家专家意见,并将这些国际指南应用和推广到我们的临床实践中。

患者与方法

成立了一个由28名专家组成的科学委员会,其中包括14名风湿病学家和14名物理医学与康复专家(其中1人还拥有免疫学博士学位)。对包括药物和非药物治疗的指南、系统评价和荟萃分析进行了审查,特别关注了方便检索的关键词。撰写了土耳其风湿病联盟意见草案,其框架包括国际治疗建议,特别是脊柱关节炎国际协会/欧洲抗风湿病联盟的建议。通过德尔菲技术确定了工作组成员对意见的认同程度。使用数字评分量表进行投票,评估每条建议的力度。

结果

专家组就五项基本原则和13条建议达成了共识,包括药物和非药物方法。所有建议都有足够的力度。

结论

土耳其风湿病联盟关于轴性脊柱关节炎管理的专家意见是基于科学证据制定的。这些建议将根据当前的进展定期更新。

相似文献

1
Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis.土耳其风湿病联盟共识报告:中轴型脊柱关节炎管理建议
Arch Rheumatol. 2018 Feb 14;33(1):1-16. doi: 10.5606/ArchRheumatol.2018.6833. eCollection 2018 Mar.
2
Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological Management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations.土耳其风湿病联盟(TLAR)类风湿关节炎药物治疗建议:2018年在当前建议指导下的更新
Arch Rheumatol. 2018 Jul 9;33(3):251-271. doi: 10.5606/ArchRheumatol.2018.6911. eCollection 2018 Sep.
3
Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.银屑病关节炎的管理:土耳其风湿病联盟(TLAR)专家意见
Arch Rheumatol. 2018 May 21;33(2):108-127. doi: 10.5606/ArchRheumatol.2018.6946. eCollection 2018 Jun.
4
The Turkish League Against Rheumatism Recommendations for the Management of Hand Osteoarthritis Under Guidance of the Current Literature and 2018 European League Against Rheumatism Recommendations.土耳其风湿病联盟在当前文献及2018年欧洲抗风湿病联盟建议指导下对手部骨关节炎管理的建议
Arch Rheumatol. 2020 Jan 8;35(3):309-320. doi: 10.46497/ArchRheumatol.2020.7693. eCollection 2020 Sep.
5
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.骨关节炎研究学会国际联盟(OARSI)髋膝关节骨关节炎管理建议,第二部分:OARSI循证专家共识指南
Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. doi: 10.1016/j.joca.2007.12.013.
6
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.骨关节炎研究学会国际联盟(OARSI)关于髋和膝骨关节炎管理的建议,第一部分:对现有治疗指南的批判性评估及当前研究证据的系统评价
Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. doi: 10.1016/j.joca.2007.06.014. Epub 2007 Aug 27.
7
The Turkish Society of Physical Medicine and Rehabilitation (TSPMR) guideline recommendations for the management of fibromyalgia syndrome.土耳其物理医学与康复学会(TSPMR)关于纤维肌痛综合征管理的指南建议。
Turk J Phys Med Rehabil. 2019 May 28;65(2):111-123. doi: 10.5606/tftrd.2019.4815. eCollection 2019 Jun.
8
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.2016 年更新的 ASAS-EULAR 中轴型脊柱关节炎管理推荐。
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
9
Treatment recommendations for the management of axial spondyloarthritis.治疗建议用于管理中轴型脊柱关节炎。
Am J Med Sci. 2013 Jun;345(6):426-30. doi: 10.1097/maj.0b013e31829360c9.
10
Agreement of Turkish physiatrists with the assessment in spondyloarthritis international society and the European league against rheumatism recommendations for the management of ankylosing spondylitis and rheumatoid arthritis.土耳其物理治疗师对国际脊柱关节炎协会的评估以及欧洲抗风湿病联盟关于强直性脊柱炎和类风湿关节炎管理建议的认同。
Open Rheumatol J. 2012;6:1-5. doi: 10.2174/1874312901206010001. Epub 2012 Mar 16.

引用本文的文献

1
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar.来自我们全国多中心注册库BioStar的脊柱关节炎合并症的真实世界数据。
Arch Rheumatol. 2022 Oct 4;38(3):333-346. doi: 10.46497/ArchRheumatol.2023.9793. eCollection 2023 Sep.
2
Ankylosing spondylitis: etiology, pathogenesis, and treatments.强直性脊柱炎:病因、发病机制及治疗方法
Bone Res. 2019 Aug 5;7:22. doi: 10.1038/s41413-019-0057-8. eCollection 2019.

本文引用的文献

1
The Fight Against Rheumatism is in its 70th Year.对抗风湿病的斗争已进入第70个年头。
Arch Rheumatol. 2017 Mar 14;32(1):1-2. eCollection 2017 Mar.
2
Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis.管理强直性脊柱炎患者的发病和治疗相关毒性。
Rheumatology (Oxford). 2018 Mar 1;57(3):419-428. doi: 10.1093/rheumatology/kex292.
3
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update.
Acta Reumatol Port. 2017 Jul-Sep;42(3):209-218.
4
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.治疗中轴型脊柱关节炎和外周型脊柱关节炎,尤其是银屑病关节炎,以达治疗目标:国际特别工作组2017年推荐更新版
Ann Rheum Dis. 2018 Jan;77(1):3-17. doi: 10.1136/annrheumdis-2017-211734. Epub 2017 Jul 6.
5
Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis.肿瘤坏死因子-α抑制剂治疗强直性脊柱炎的安全性:一项荟萃分析。
Medicine (Baltimore). 2017 Jun;96(25):e7145. doi: 10.1097/MD.0000000000007145.
6
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.2017年美国风湿病学会/美国髋膝关节外科医师协会关于接受择期全髋关节或全膝关节置换术的风湿病患者围手术期抗风湿药物管理的指南。
J Arthroplasty. 2017 Sep;32(9):2628-2638. doi: 10.1016/j.arth.2017.05.001. Epub 2017 Jun 16.
7
Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis.切换肿瘤坏死因子抑制剂治疗中轴型脊柱关节炎。
Semin Arthritis Rheum. 2017 Dec;47(3):343-350. doi: 10.1016/j.semarthrit.2017.04.005. Epub 2017 Apr 25.
8
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.一项针对 802 例炎症性关节炎患者的全国性非医学性从原研英夫利昔单抗转换为生物类似药 CT-P13 的研究:DANBIO 注册研究的 1 年临床结果。
Ann Rheum Dis. 2017 Aug;76(8):1426-1431. doi: 10.1136/annrheumdis-2016-210742. Epub 2017 May 4.
9
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.类风湿关节炎、银屑病关节炎和强直性脊柱炎二线生物制剂治疗的优化。
Semin Arthritis Rheum. 2017 Oct;47(2):183-192. doi: 10.1016/j.semarthrit.2017.03.008. Epub 2017 Mar 22.
10
Treat to Target in Axial Spondyloarthritis: What Are the Issues?中轴型脊柱关节炎的治疗达标:存在哪些问题?
Curr Rheumatol Rep. 2017 May;19(5):22. doi: 10.1007/s11926-017-0648-6.